Lumos Pharma Ownership 2024 | Who Owns Lumos Pharma Now?
Institutional Ownership
25.64%
Insider Ownership
34.80%
Retail Ownership
39.56%
Institutional Holders
35.00
Lumos Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | 5.12% | 0.00% | 414,981 | -570 | -0.14% | 962,755 | Jun 30, 2024 |
GOLDMAN SACHS GROUP INC | 5.02% | 0.00% | 406,611 | -1 | -0.00% | 943,338 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.01% | - | 244,082 | - | - | 566,270 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 2.66% | 0.00% | 215,814 | -2,200 | -1.01% | 500,688 | Jun 30, 2024 |
ACUITAS INVESTMENTS, LLC | 1.75% | 0.18% | 141,435 | 746 | 0.53% | 328,129 | Jun 30, 2024 |
JEFFERIES FINANCIAL GROUP INC. | 1.49% | 0.00% | 120,651 | - | - | 279,910 | Jun 30, 2024 |
LION POINT CAPITAL, LP | 1.12% | 0.38% | 90,794 | - | - | 210,642 | Jun 30, 2024 |
GREENWICH WEALTH MANAGEMENT LLC | 0.94% | 0.01% | 76,341 | - | - | 177,000 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.63% | - | 50,727 | 3,131 | 6.58% | 117,708 | Jun 30, 2024 |
BLACKROCK INC. | 0.51% | - | 41,104 | - | - | 95,361 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.46% | - | 37,018 | -561 | -1.49% | 85,882 | Jun 30, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.37% | 0.00% | 30,013 | 14,000 | 87.43% | 69,630 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.37% | - | 29,587 | -30 | -0.10% | 68,631 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.34% | 0.00% | 27,643 | - | - | 64,132 | Jun 30, 2024 |
MARQUETTE ASSET MANAGEMENT, LLC | 0.32% | 0.01% | 25,760 | - | - | 59,764 | Jun 30, 2024 |
ENVESTNET ASSET MANAGEMENT INC | 0.24% | - | 19,475 | 3,360 | 20.85% | 45,182 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.23% | 0.00% | 18,945 | -19,872 | -51.19% | 43,952 | Jun 30, 2024 |
BANK OF NEW YORK MELLON CORP | 0.15% | - | 11,858 | - | - | 27,509 | Jun 30, 2024 |
WEALTH ADVISORS OF IOWA, LLC | 0.14% | 0.02% | 11,699 | - | - | 27,142 | Jun 30, 2024 |
STATE STREET CORP | 0.14% | - | 11,237 | - | - | 26,070,000 | Jun 30, 2024 |
Lumos Pharma's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 5.12% of the company's total share outstanding, currently valued at $962.75K. The top 10 institutional shareholders own together 22.24% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
LION POINT CAPITAL, LP | 1.12% | 0.38% | 90,794 | - | - | 210,642 | Jun 30, 2024 |
ACUITAS INVESTMENTS, LLC | 1.75% | 0.18% | 141,435 | 746 | 0.53% | 328,129 | Jun 30, 2024 |
WEALTH ADVISORS OF IOWA, LLC | 0.14% | 0.02% | 11,699 | - | - | 27,142 | Jun 30, 2024 |
GREENWICH WEALTH MANAGEMENT LLC | 0.94% | 0.01% | 76,341 | - | - | 177,000 | Jun 30, 2024 |
MARQUETTE ASSET MANAGEMENT, LLC | 0.32% | 0.01% | 25,760 | - | - | 59,764 | Jun 30, 2024 |
PALADIN ADVISORY GROUP, LLC | 0.05% | 0.01% | 4,387 | - | - | 9,928 | Jun 30, 2024 |
KEY FINANCIAL INC | 0.13% | 0.01% | 10,927 | - | - | 25,351 | Jun 30, 2024 |
JEFFERIES FINANCIAL GROUP INC. | 1.49% | 0.00% | 120,651 | - | - | 279,910 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.34% | 0.00% | 27,643 | - | - | 64,132 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 500 | 500 | 100.00% | 1,160 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 2.66% | 0.00% | 215,814 | -2,200 | -1.01% | 500,688 | Jun 30, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.37% | 0.00% | 30,013 | 14,000 | 87.43% | 69,630 | Jun 30, 2024 |
WEST FINANCIAL ADVISORS, LLC | 0.01% | 0.00% | 784 | - | - | 1,819 | Jun 30, 2024 |
ATRIA INVESTMENTS, INC | 0.13% | 0.00% | 10,803 | 10,803 | 100.00% | 25,063 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 5.12% | 0.00% | 414,981 | -570 | -0.14% | 962,755 | Jun 30, 2024 |
GOLDMAN SACHS GROUP INC | 5.02% | 0.00% | 406,611 | -1 | -0.00% | 943,338 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 3,582 | 891 | 33.11% | 8,310 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.23% | 0.00% | 18,945 | -19,872 | -51.19% | 43,952 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.46% | - | 37,018 | -561 | -1.49% | 85,882 | Jun 30, 2024 |
LIVE OAK INVESTMENT PARTNERS | 0.00% | - | 11 | 11 | 100.00% | 26 | Jun 30, 2024 |
The largest Lumos Pharma shareholder by % of total assets is LION POINT CAPITAL, LP. The company owns 90.79K shares of Lumos Pharma (LUMO), representing 0.38% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
PRIVATE ADVISOR GROUP, LLC | 0.37% | 0.00% | 30,013 | 14,000 | 87.43% | 69,630 | Jun 30, 2024 |
ATRIA INVESTMENTS, INC | 0.13% | 0.00% | 10,803 | 10,803 | 100.00% | 25,063 | Jun 30, 2024 |
ENVESTNET ASSET MANAGEMENT INC | 0.24% | - | 19,475 | 3,360 | 20.85% | 45,182 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.63% | - | 50,727 | 3,131 | 6.58% | 117,708 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 3,582 | 891 | 33.11% | 8,310 | Jun 30, 2024 |
ACUITAS INVESTMENTS, LLC | 1.75% | 0.18% | 141,435 | 746 | 0.53% | 328,129 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 500 | 500 | 100.00% | 1,160 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 310 | 156 | 101.30% | 720 | Jun 30, 2024 |
MORGAN STANLEY | 0.00% | - | 277 | 111 | 66.87% | 643 | Jun 30, 2024 |
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.00% | - | 38 | 38 | 100.00% | 88 | Jun 30, 2024 |
LIVE OAK INVESTMENT PARTNERS | 0.00% | - | 11 | 11 | 100.00% | 26 | Jun 30, 2024 |
JONES FINANCIAL COMPANIES LLLP | - | - | 4 | 4 | 100.00% | 9 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 3 | - | - | 7 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.02% | - | 1,800 | - | - | 4,176 | Jun 30, 2024 |
STATE STREET CORP | 0.14% | - | 11,237 | - | - | 26,070,000 | Jun 30, 2024 |
BLACKROCK INC. | 0.51% | - | 41,104 | - | - | 95,361 | Jun 30, 2024 |
BANK OF NEW YORK MELLON CORP | 0.15% | - | 11,858 | - | - | 27,509 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.01% | - | 244,082 | - | - | 566,270 | Jun 30, 2024 |
WEST FINANCIAL ADVISORS, LLC | 0.01% | 0.00% | 784 | - | - | 1,819 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.34% | 0.00% | 27,643 | - | - | 64,132 | Jun 30, 2024 |
As of Jun 30 2024, Lumos Pharma's largest institutional buyer is PRIVATE ADVISOR GROUP, LLC. The company purchased 14.00K stocks of LUMO, valued at $69.63K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BLACKSTONE INC. | - | - | - | -78,624 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.23% | 0.00% | 18,945 | -19,872 | -51.19% | 43,952 | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -3,733 | -100.00% | - | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 2.66% | 0.00% | 215,814 | -2,200 | -1.01% | 500,688 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 5.12% | 0.00% | 414,981 | -570 | -0.14% | 962,755 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.46% | - | 37,018 | -561 | -1.49% | 85,882 | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.37% | - | 29,587 | -30 | -0.10% | 68,631 | Jun 30, 2024 |
JPMORGAN CHASE & CO | 0.00% | - | 13 | -28 | -68.29% | 30 | Jun 30, 2024 |
GLOBAL RETIREMENT PARTNERS, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
GOLDMAN SACHS GROUP INC | 5.02% | 0.00% | 406,611 | -1 | -0.00% | 943,338 | Jun 30, 2024 |
LION POINT CAPITAL, LP | 1.12% | 0.38% | 90,794 | - | - | 210,642 | Jun 30, 2024 |
WEALTH ADVISORS OF IOWA, LLC | 0.14% | 0.02% | 11,699 | - | - | 27,142 | Jun 30, 2024 |
GREENWICH WEALTH MANAGEMENT LLC | 0.94% | 0.01% | 76,341 | - | - | 177,000 | Jun 30, 2024 |
MARQUETTE ASSET MANAGEMENT, LLC | 0.32% | 0.01% | 25,760 | - | - | 59,764 | Jun 30, 2024 |
PALADIN ADVISORY GROUP, LLC | 0.05% | 0.01% | 4,387 | - | - | 9,928 | Jun 30, 2024 |
KEY FINANCIAL INC | 0.13% | 0.01% | 10,927 | - | - | 25,351 | Jun 30, 2024 |
JEFFERIES FINANCIAL GROUP INC. | 1.49% | 0.00% | 120,651 | - | - | 279,910 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.34% | 0.00% | 27,643 | - | - | 64,132 | Jun 30, 2024 |
WEST FINANCIAL ADVISORS, LLC | 0.01% | 0.00% | 784 | - | - | 1,819 | Jun 30, 2024 |
As of Jun 30 2024, Lumos Pharma's biggest institutional seller is BLACKSTONE INC.. The company sold -78.62K shares of LUMO, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ATRIA INVESTMENTS, INC | 0.13% | 0.00% | 10,803 | 10,803 | 100.00% | 25,063 | Jun 30, 2024 |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.00% | 500 | 500 | 100.00% | 1,160 | Jun 30, 2024 |
LIVE OAK INVESTMENT PARTNERS | 0.00% | - | 11 | 11 | 100.00% | 26 | Jun 30, 2024 |
JONES FINANCIAL COMPANIES LLLP | - | - | 4 | 4 | 100.00% | 9 | Jun 30, 2024 |
Lumos Pharma's largest new institutional shareholder by number of shares is ATRIA INVESTMENTS, INC, purchased 10.80K shares, valued at $25.06K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BLACKSTONE INC. | - | - | - | -78,624 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -3,733 | -100.00% | - | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
GLOBAL RETIREMENT PARTNERS, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
Lumos Pharma's largest sold out institutional shareholder by shares sold is BLACKSTONE INC., sold -78.62K shares, valued at -, as of undefined.
Lumos Pharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
BRIDGEWAY FUNDS INC | 0.01% | 26,744 | -20,000 | -42.79% | Mar 28, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 238,150 | -50,828 | -17.59% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 44,400 | -190 | -0.43% | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 5,932 | - | - | Mar 31, 2024 |
Meeder Funds | 0.00% | 119 | - | - | Mar 31, 2024 |
Dimensional ETF Trust | 0.00% | 3,699 | 3,695 | 92375.00% | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 3,556 | - | - | Jan 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 300 | 200 | 200.00% | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 562 | - | - | Jan 31, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 2,748 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 245 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 2,356 | - | - | Mar 31, 2024 |
Lumos Pharma's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 26.74K shares, compromising 0.01% of its total assets.
Lumos Pharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 35 | - |
31 Mar, 24 | 35 | -5.41% |
31 Dec, 23 | 37 | 12.12% |
30 Sep, 23 | 33 | -2.94% |
30 Jun, 23 | 34 | - |
31 Mar, 23 | 34 | -8.11% |
31 Dec, 22 | 37 | 12.12% |
30 Sep, 22 | 33 | -5.71% |
30 Jun, 22 | 35 | 2.94% |
31 Mar, 22 | 34 | -5.56% |
31 Dec, 21 | 36 | 9.09% |
30 Sep, 21 | 33 | -5.71% |
30 Jun, 21 | 35 | - |
31 Mar, 21 | 35 | -20.45% |
31 Dec, 20 | 44 | 25.71% |
30 Sep, 20 | 35 | -14.63% |
30 Jun, 20 | 41 | -8.89% |
31 Mar, 20 | 45 | - |
As of 30 Jun 24, 35 institutions are holding Lumos Pharma's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 2,077,959 | -4.52% |
31 Mar, 24 | 2,176,429 | -8.07% |
31 Dec, 23 | 2,367,466 | -3.00% |
30 Sep, 23 | 2,440,661 | 1.96% |
30 Jun, 23 | 2,393,810 | 7.21% |
31 Mar, 23 | 2,232,914 | -7.42% |
31 Dec, 22 | 2,411,837 | -5.89% |
30 Sep, 22 | 2,562,753 | 7.86% |
30 Jun, 22 | 2,375,895 | -4.25% |
31 Mar, 22 | 2,481,432 | -8.16% |
31 Dec, 21 | 2,701,890 | -5.74% |
30 Sep, 21 | 2,866,344 | -10.51% |
30 Jun, 21 | 3,202,820 | -3.39% |
31 Mar, 21 | 3,315,233 | -12.05% |
31 Dec, 20 | 3,769,569 | 3.70% |
30 Sep, 20 | 3,634,986 | 2.04% |
30 Jun, 20 | 3,562,247 | 8.67% |
31 Mar, 20 | 3,278,022 | - |
Lumos Pharma (LUMO) has 2.08M shares outstanding as of 30 Jun 24, down -4.52% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 25.64% | 3.55% |
31 Mar, 24 | 26.86% | 3.05% |
31 Dec, 23 | 29.67% | 3.32% |
30 Sep, 23 | 29.89% | 3.54% |
30 Jun, 23 | 29.05% | 3.96% |
31 Mar, 23 | 27.10% | 3.27% |
31 Dec, 22 | 28.80% | 3.09% |
30 Sep, 22 | 30.55% | 3.79% |
30 Jun, 22 | 28.40% | 3.22% |
31 Mar, 22 | 29.69% | 2.82% |
31 Dec, 21 | 32.42% | 2.76% |
30 Sep, 21 | 34.30% | 2.55% |
30 Jun, 21 | 36.68% | 2.31% |
31 Mar, 21 | 39.86% | 1.29% |
31 Dec, 20 | 55.62% | 2.90% |
30 Sep, 20 | 43.83% | 2.38% |
30 Jun, 20 | 42.96% | 2.75% |
31 Mar, 20 | 39.53% | - |
As of 30 Jun 24, Lumos Pharma is held by 25.64% institutional shareholders, representing a 3.55% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 13 | 30.00% |
31 Mar, 24 | 10 | -9.09% |
31 Dec, 23 | 11 | 37.50% |
30 Sep, 23 | 8 | -11.11% |
30 Jun, 23 | 9 | -10.00% |
31 Mar, 23 | 10 | -47.37% |
31 Dec, 22 | 19 | 216.67% |
30 Sep, 22 | 6 | -33.33% |
30 Jun, 22 | 9 | - |
31 Mar, 22 | 9 | -30.77% |
31 Dec, 21 | 13 | 8.33% |
30 Sep, 21 | 12 | 33.33% |
30 Jun, 21 | 9 | -50.00% |
31 Mar, 21 | 18 | -10.00% |
31 Dec, 20 | 20 | 66.67% |
30 Sep, 20 | 12 | -25.00% |
30 Jun, 20 | 16 | -62.79% |
31 Mar, 20 | 43 | - |
13 institutional shareholders have increased their position in LUMO stock as of 30 Jun 24 compared to 10 in the previous quarter (a 30.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 7 | - |
31 Mar, 24 | 7 | 40.00% |
31 Dec, 23 | 5 | -54.55% |
30 Sep, 23 | 11 | 83.33% |
30 Jun, 23 | 6 | 50.00% |
31 Mar, 23 | 4 | -20.00% |
31 Dec, 22 | 5 | -37.50% |
30 Sep, 22 | 8 | -27.27% |
30 Jun, 22 | 11 | 83.33% |
31 Mar, 22 | 6 | -33.33% |
31 Dec, 21 | 9 | 12.50% |
30 Sep, 21 | 8 | -33.33% |
30 Jun, 21 | 12 | 200.00% |
31 Mar, 21 | 4 | -66.67% |
31 Dec, 20 | 12 | 9.09% |
30 Sep, 20 | 11 | 37.50% |
30 Jun, 20 | 8 | - |
31 Mar, 20 | - | - |
7 institutional shareholders have reduced their position in LUMO stock as of 30 Jun 24 compared to 7 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 35 | - | 2,077,959 | -4.52% | 25.64% | 3.55% | 13 | 30.00% | 7 | - |
31 Mar, 24 | 35 | -5.41% | 2,176,429 | -8.07% | 26.86% | 3.05% | 10 | -9.09% | 7 | 40.00% |
31 Dec, 23 | 37 | 12.12% | 2,367,466 | -3.00% | 29.67% | 3.32% | 11 | 37.50% | 5 | -54.55% |
30 Sep, 23 | 33 | -2.94% | 2,440,661 | 1.96% | 29.89% | 3.54% | 8 | -11.11% | 11 | 83.33% |
30 Jun, 23 | 34 | - | 2,393,810 | 7.21% | 29.05% | 3.96% | 9 | -10.00% | 6 | 50.00% |
31 Mar, 23 | 34 | -8.11% | 2,232,914 | -7.42% | 27.10% | 3.27% | 10 | -47.37% | 4 | -20.00% |
31 Dec, 22 | 37 | 12.12% | 2,411,837 | -5.89% | 28.80% | 3.09% | 19 | 216.67% | 5 | -37.50% |
30 Sep, 22 | 33 | -5.71% | 2,562,753 | 7.86% | 30.55% | 3.79% | 6 | -33.33% | 8 | -27.27% |
30 Jun, 22 | 35 | 2.94% | 2,375,895 | -4.25% | 28.40% | 3.22% | 9 | - | 11 | 83.33% |
31 Mar, 22 | 34 | -5.56% | 2,481,432 | -8.16% | 29.69% | 2.82% | 9 | -30.77% | 6 | -33.33% |
31 Dec, 21 | 36 | 9.09% | 2,701,890 | -5.74% | 32.42% | 2.76% | 13 | 8.33% | 9 | 12.50% |
30 Sep, 21 | 33 | -5.71% | 2,866,344 | -10.51% | 34.30% | 2.55% | 12 | 33.33% | 8 | -33.33% |
30 Jun, 21 | 35 | - | 3,202,820 | -3.39% | 36.68% | 2.31% | 9 | -50.00% | 12 | 200.00% |
31 Mar, 21 | 35 | -20.45% | 3,315,233 | -12.05% | 39.86% | 1.29% | 18 | -10.00% | 4 | -66.67% |
31 Dec, 20 | 44 | 25.71% | 3,769,569 | 3.70% | 55.62% | 2.90% | 20 | 66.67% | 12 | 9.09% |
30 Sep, 20 | 35 | -14.63% | 3,634,986 | 2.04% | 43.83% | 2.38% | 12 | -25.00% | 11 | 37.50% |
30 Jun, 20 | 41 | -8.89% | 3,562,247 | 8.67% | 42.96% | 2.75% | 16 | -62.79% | 8 | - |
31 Mar, 20 | 45 | - | 3,278,022 | - | 39.53% | - | 43 | - | - | - |
Lumos Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Lumos Pharma's stock was made by Pitukcheewanont Pisit Duke on Jan 10 2024, selling - shares at - per share (valued at -).
Lumos Pharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 1 | - |
Q1 2024 | - | 2 | - |
Q3 2023 | - | 3 | - |
Q2 2023 | 6 | 6 | 100.00% |
Q1 2023 | 12 | 7 | 171.43% |
Q4 2022 | 1 | - | - |
Q3 2022 | 4 | 1 | 400.00% |
Q1 2022 | 10 | 5 | 200.00% |
Q3 2021 | 25 | 3 | 833.33% |
Q2 2021 | 11 | 7 | 157.14% |
Q1 2021 | 12 | 9 | 133.33% |
Q2 2020 | 22 | - | - |
Q1 2020 | 1 | 3 | 33.33% |
Q3 2019 | 134 | 67 | 200.00% |
Q2 2019 | 5 | 3 | 166.67% |
Q1 2019 | 4 | 3 | 133.33% |
Q4 2018 | 1 | 4 | 25.00% |
Q3 2018 | 4 | 6 | 66.67% |
Q2 2018 | 6 | - | - |
Q1 2018 | 6 | 11 | 54.55% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Lumos Pharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q1 2024 | - | - | - |
Q3 2023 | - | 1 | - |
Q2 2023 | - | 1 | - |
Q1 2023 | - | 1 | - |
Q4 2022 | 1 | - | - |
Q3 2022 | 4 | - | - |
Q1 2022 | - | - | - |
Q3 2021 | 22 | 1 | 2200.00% |
Q2 2021 | - | - | - |
Q1 2021 | - | 7 | - |
Q2 2020 | - | - | - |
Q1 2020 | - | - | - |
Q3 2019 | - | - | - |
Q2 2019 | - | - | - |
Q1 2019 | - | - | - |
Q4 2018 | - | - | - |
Q3 2018 | - | 1 | - |
Q2 2018 | - | - | - |
Q1 2018 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lumos Pharma's stocks.
LUMO Ownership FAQ
Who Owns Lumos Pharma?
Lumos Pharma is owned by institutional shareholders (25.64%), insiders (34.80%), and public (39.56%). The largest institutional shareholder of Lumos Pharma is WELLS FARGO & COMPANY/MN (5.12% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.01% of total shares).
Who are the major institutional shareholders of Lumos Pharma?
Lumos Pharma's major institutional shareholders are WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and ACUITAS INVESTMENTS, LLC. The top five shareholders own together 17.56% of the company's share outstanding.
How many Lumos Pharma shareholders are there?
As of Jun 2024, there are 35 institutional shareholders of Lumos Pharma.
What percentage of Lumos Pharma is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 414.98K shares of Lumos Pharma, representing 5.12% of the company's total shares outstanding, valued at $962.76K (as of Jun 2024).
What percentage of Lumos Pharma is owned by GOLDMAN SACHS GROUP INC?
As of Jun 2024, GOLDMAN SACHS GROUP INC holds 406.61K shares of Lumos Pharma (LUMO), compromising 5.02% of the company, valued at $943.34K.
What percentage of Lumos Pharma is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Lumos Pharma. The company owns 244.08K of the company's shares outstanding (worth $566.27K).